Northland Capmk Has Negative Estimate for DocGo Q2 Earnings

DocGo Inc. (NASDAQ:DCGO - Free Report) - Equities research analysts at Northland Capmk dropped their Q2 2025 earnings per share estimates for DocGo in a research report issued on Sunday, May 11th. Northland Capmk analyst M. Latimore now anticipates that the company will earn ($0.07) per share for the quarter, down from their prior forecast of $0.03. The consensus estimate for DocGo's current full-year earnings is $0.25 per share. Northland Capmk also issued estimates for DocGo's Q3 2025 earnings at ($0.06) EPS, Q4 2025 earnings at ($0.05) EPS and FY2025 earnings at ($0.26) EPS.

DocGo (NASDAQ:DCGO - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported ($0.09) earnings per share for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.08). DocGo had a net margin of 4.35% and a return on equity of 8.90%. The firm had revenue of $96.03 million during the quarter, compared to the consensus estimate of $104.25 million.

DCGO has been the subject of a number of other research reports. Needham & Company LLC reduced their price target on DocGo from $4.00 to $3.00 and set a "buy" rating for the company in a research report on Friday, May 9th. BTIG Research cut DocGo from a "buy" rating to a "neutral" rating in a research report on Friday, May 9th. Stifel Nicolaus cut their target price on DocGo from $6.50 to $5.50 and set a "buy" rating for the company in a research report on Friday, February 28th. Deutsche Bank Aktiengesellschaft cut DocGo from a "buy" rating to a "hold" rating and cut their target price for the stock from $5.00 to $2.85 in a research report on Friday, February 28th. Finally, Canaccord Genuity Group reiterated a "hold" rating and set a $1.45 target price (down previously from $5.00) on shares of DocGo in a research report on Monday, May 12th. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $3.56.

DocGo Trading Down 1.7%

DCGO stock traded down $0.03 during trading on Wednesday, reaching $1.45. The stock had a trading volume of 315,166 shares, compared to its average volume of 789,620. DocGo has a 52 week low of $1.35 and a 52 week high of $5.68. The stock's 50 day moving average is $2.37 and its two-hundred day moving average is $3.61. The firm has a market cap of $147.37 million, a PE ratio of 5.16, a PEG ratio of 14.16 and a beta of 1.14.

Hedge Funds Weigh In On DocGo

Several institutional investors have recently added to or reduced their stakes in the company. S Squared Technology LLC lifted its stake in shares of DocGo by 36.8% in the 1st quarter. S Squared Technology LLC now owns 1,890,976 shares of the company's stock valued at $4,992,000 after purchasing an additional 508,590 shares during the last quarter. Punch & Associates Investment Management Inc. lifted its stake in shares of DocGo by 17.4% in the 1st quarter. Punch & Associates Investment Management Inc. now owns 2,201,667 shares of the company's stock valued at $5,812,000 after purchasing an additional 325,760 shares during the last quarter. AQR Capital Management LLC lifted its stake in shares of DocGo by 219.1% in the 1st quarter. AQR Capital Management LLC now owns 476,645 shares of the company's stock valued at $1,258,000 after purchasing an additional 327,269 shares during the last quarter. Birchview Capital LP lifted its stake in shares of DocGo by 13.1% in the 1st quarter. Birchview Capital LP now owns 864,062 shares of the company's stock valued at $2,281,000 after purchasing an additional 100,000 shares during the last quarter. Finally, Penn Capital Management Company LLC lifted its stake in shares of DocGo by 257.8% in the 1st quarter. Penn Capital Management Company LLC now owns 48,774 shares of the company's stock valued at $129,000 after purchasing an additional 35,142 shares during the last quarter. Hedge funds and other institutional investors own 56.44% of the company's stock.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.